Bugs as drugs: parasite biomolecules as novel therapeutics against breast cancer
American Journal of Physiology-Cell Physiology · 01.04.2026 · 330 (4) · C1067-C1080
DOI: 10.1152/ajpcell.00870.2025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.04.2026. Verfasst von Said B Gonzalez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College, Nashville, Tennessee, United States. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Parasites. Die Arbeit nennt 131 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NEI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Contemporary breast cancer treatments include chemotherapy, surgery, and radiation therapy, all of which are invasive or accompanied by severe side effects. Although emerging research suggests that parasites have unique features that may be capitalized to develop innovative cancer treatments, the idea of using parasites for therapeutic purposes has been around for more than 3,500 yr. Parasites constitute a novel source of biomolecules with potent immunomodulatory and antitumor properties. This review summarizes our current knowledge on how components of the host response to parasite infection, specifically the inflammatory response, could be exploited to develop novel therapeutics for breast cancer. By identifying the molecular mechanisms behind parasite-induced antitumor properties, pathogen biomolecules could be potentially used as effective therapeutic alternatives or additives against breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College, Nashville, Tennessee, United States.
- Research Service, Nashville VA Medical Center, Nashville, Tennessee, United States.
ORCID-Profile: Said B Gonzalez, Pushkar Shivam, Destiny Ball, Sewedo B Ajisegiri, Smita Misra, Ashley L Mutchler, Merry L Lindsey, Amos M Sakwe, Pius N Nde
Förderung
- NIGMS NIH HHS
- NEI NIH HHS
- NIAID NIH HHS
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- U.S. Department of Energy (DOE)
- National Science Foundation (NSF)
- VA | Office of Research and Development (ORD)
- American Heart Association (AHA)
Zitieren
APA
Gonzalez, S. B., Shivam, P., Ball, D., Ajisegiri, S. B., Osi, I., Misra, S., Mutchler, A. L., Lindsey, M. L., Martin, P. M., Sakwe, A. M., & Nde, P. N. (2026). Bugs as drugs: parasite biomolecules as novel therapeutics against breast cancer. American Journal of Physiology-Cell Physiology, 330(4), C1067-C1080. https://doi.org/10.1152/ajpcell.00870.2025
Vancouver
Gonzalez SB, Shivam P, Ball D, Ajisegiri SB, Osi I, Misra S, et al. Bugs as drugs: parasite biomolecules as novel therapeutics against breast cancer. American Journal of Physiology-Cell Physiology. 2026;330(4):C1067-C1080. doi:10.1152/ajpcell.00870.2025
BibTeX
@article{Gonzalez2026,
author = {Gonzalez, Said B and Shivam, Pushkar and Ball, Destiny and Ajisegiri, Sewedo B and Osi, Inmar and Misra, Smita and Mutchler, Ashley L and Lindsey, Merry L and Martin, Pamela M and Sakwe, Amos M and Nde, Pius N},
title = {Bugs as drugs: parasite biomolecules as novel therapeutics against breast cancer},
journal = {American Journal of Physiology-Cell Physiology},
year = {2026},
volume = {330},
number = {4},
pages = {C1067--C1080},
doi = {10.1152/ajpcell.00870.2025}
}
EUVIMED